日本の患者エンゲージメントソリューション市場：2025年～2033年

日本の患者エンゲージメントソリューションの市場規模は、2024年に2兆7,314億1,000万米ドルとなりました。同市場は、2033年に16兆1,672億6,000万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは19.4%となる見込みです。

患者エンゲージメントソリューションは、患者をヘルスケアジャーニーに巻き込み、コミュニケーションを改善し、健康的な行動を促進し、医療記録へのリアルタイムアクセスを可能にするデジタルツールです。これらのツールは、健康に関する十分な情報に基づいた意思決定を可能にし、慢性疾患の管理をサポートし、病院の再入院率を低下させ、ケアの質を高める。バリューベースのケアモデルとデジタルヘルス変革が登場するにつれ、これらのツールはますますヘルスケアシステムに統合されるようになっています。予防医療と患者中心のアプローチが重視される中、患者エンゲージメントソリューションは、健康アウトカムの改善と協力的なヘルスケア環境の育成に不可欠です。

患者エンゲージメントソリューション市場は、より良い健康アウトカム、患者満足度、コスト効率を優先するバリューベース・ケア・モデルへの移行により成長しています。ヘルスケアプロバイダーは、患者とプロバイダー間のコミュニケーションとコラボレーションを強化するためにデジタルツールを採用しています。モバイルアプリ、遠隔モニタリングシステム、オンラインポータルなどのこれらのソリューションは、患者の経過を追跡し、治療のアドヒアランスを促し、病院の再入院を減らすのに役立ち、これらの目標を達成するために不可欠です。

さらに、日本政府とヘルスケアプロバイダーは、サービスの質と持続可能性を向上させるため、データ主導のアプローチ、統合ケアシステム、アウトカムに基づく報酬体系を導入しています。この動向は、デジタルヘルス、慢性疾患管理、個別化医療におけるイノベーションを促進し、バリューベース・ケアを日本の将来のヘルスケア戦略の重要な柱として位置づけると予想されます。

患者エンゲージメント技術は普及しつつありますが、データのプライバシーとセキュリティに関する懸念は依然として大きな課題です。これらのソリューションでは、機密性の高い患者情報の収集、保管、交換が行われるため、サイバー攻撃や侵害の影響を受けやすいです。HIPAAやGDPRのような規制の枠組みを遵守することは極めて重要であり、これを怠ると法的な結果を招き、患者の信頼を失う可能性があります。サイバーセキュリティ対策に多額の投資をすると、運用コストが増加し、新技術の導入が遅れる可能性があります。

当レポートでは、日本の患者エンゲージメントソリューション市場について調査し、市場の概要とともに、コンポーネント別、デリバリーモード別、用途別、治療分野別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第4章 戦略的洞察と業界展望

• 市場のリーダーとパイオニア
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の調査
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格動向
• キーオピニオンリーダー

第5章 コンポーネント別

• テーブルトップデバイス
• ハードウェア
• サービス

第6章 デリバリーモード別

• ウェブベース
• クラウドベース
• オンプレミス

第7章 用途別

• 健康管理
• 在宅健康管理
• 社会行動マネジメント
• 財務健全性管理

第8章 治療分野別

• 病院と診療所
• フィットネス
• 婦人科
• メンタルヘルス
• その他

第9章 エンドユーザー別

• プロバイダー
• 支払者
• 患者
• その他

第10章 競合情勢と市場ポジショニング

• 競合状況の概要と主要市場参入企業
• 市場シェア分析とポジショニングマトリックス
• 戦略的パートナーシップ、合併・買収
• 製品ポートフォリオとイノベーションにおける主な発展
• 企業ベンチマーク

第11章 企業プロファイル

• CureApp
• 会社概要
• 製品ポートフォリオ
• 財務概要
• 主な発展
• SWOT分析
• Oracle Corporation
• NTT Data
• Fujitsu Limited
• M3

第12章 仮定と調査手法

第13章 付録

The Japan patient engagement solutions market reached US$ 2731.41 billion in 2024 and is expected to reach US$ 16,167.26 billion by 2033, growing at a CAGR of 19.4% during the forecast period 2025-2033.

Patient engagement solutions are digital tools that involve patients in their healthcare journey, improving communication, promoting healthy behaviors, and enabling real-time access to medical records. These tools enable informed decisions about health, support chronic disease management, reduce hospital readmission rates, and enhance care quality. As value-based care models and digital health transformation emerge, these tools are increasingly integrated into healthcare systems. With a growing emphasis on preventive care and patient-centered approaches, patient engagement solutions are crucial for improving health outcomes and fostering a collaborative healthcare environment.

Market Dynamics: Drivers & Restraints

Rising Demand for Value-Based Care

The patient engagement solutions market is growing due to the country's shift towards value-based care models, which prioritize better health outcomes, patient satisfaction, and cost efficiency. Healthcare providers are adopting digital tools to enhance communication and collaboration between patients and providers. These solutions, such as mobile apps, remote monitoring systems, and online portals, help track patient progress, encourage treatment adherence, and reduce hospital readmissions, making them critical for achieving these goals.

Moreover, the Japan government and healthcare providers are implementing data-driven approaches, integrated care systems, and outcome-based reimbursement structures to improve service quality and sustainability. This trend is expected to drive innovation in digital health, chronic disease management, and personalized medicine, positioning value-based care as a key pillar of Japan's future healthcare strategy.

Data Privacy and Security Concerns

Patient engagement technologies are gaining popularity, but concerns about data privacy and security remain a significant challenge. These solutions involve the collection, storage, and exchange of sensitive patient information, which is vulnerable to cyberattacks and breaches. Compliance with regulatory frameworks like HIPAA and GDPR is crucial, and failure to do so can lead to legal consequences and loss of patient trust. Investing heavily in cybersecurity measures can increase operational costs and slow new technology implementation.

Segment Analysis

The Japan patient engagement solutions market is segmented based on component, delivery mode, application, therapeutic area, and End-User.

Component:

The software from the component segment is expected to dominate the Japan patient engagement solutions market with the highest market share

Software is a set of instructions, programs, or data used to operate computers and perform specific tasks. It is intangible and tells hardware what to do, ranging from operating systems like Windows or macOS to apps like Microsoft Word, mobile apps, games, and specialized programs for businesses and healthcare. Software is the brain behind the machine, enabling tasks like calculating, displaying information, managing files, and communicating over the internet.

The patient engagement solutions market is gaining popularity due to the growing use of digital health tools, the burden of chronic diseases, and government initiatives promoting eHealth and digital health transformation. Software platforms can efficiently provide continuous patient monitoring and communication, while the integration of artificial intelligence and data analytics enhances personalization and clinical decision-making. As a result, software is becoming an indispensable component of modern patient engagement strategies.

For instance, in January 2023, Fujitsu and Sapporo Medical University launched a joint project to enable data portability for patients' healthcare data, including electronic health records (EHRs) and personal health records (PHRs). The project will involve Fujitsu developing a mobile app for iPhone users to view healthcare data and a cloud-based platform for managing patients' health data. This marks the first initiative in Japan to link electronic medical records with Apple's Health app.

Competitive Landscape

The major country players in the Japan patient engagement solutions market include CureApp, Oracle Corporation, NTT Data, Fujitsu Limited, and M3, among others.

Why Purchase the Report?

• Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan patient engagement solutions market report delivers a detailed analysis with 30 key tables, more than 35 visually impactful figures and 115 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Component
• 2.4. Snippet by Delivery Mode
• 2.5. Snippet by Application
• 2.6. Snippet by Therapeutic Area
• 2.7. Snippet by End-User

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising Demand for Value-Based Care
    • 3.1.1.2. Growing Digital Health Adoption and Telemedicine Services
  • 3.1.2. Restraints
    • 3.1.2.1. Data Privacy and Security Concerns
    • 3.1.2.2. Limited Digital Literacy Among the Elderly Population
  • 3.1.3. Opportunity
    • 3.1.3.1. Integration of AI and Machine Learning in Engagement Platforms
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with the largest-selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Porter's Five Force Analysis
• 4.6. Supply Chain Analysis
• 4.7. Patent Analysis
• 4.8. SWOT Analysis
• 4.9. Unmet Needs and Gaps
• 4.10. Recommended Strategies for Market Entry and Expansion
• 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.12. Pricing Analysis and Price Dynamics
• 4.13. Key Opinion Leaders

5. By Component

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 5.1.2. Market Attractiveness Index, By Component
• 5.2. Table-top Devices*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Hardware
• 5.4. Services

6. By Delivery Mode

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 6.1.2. Market Attractiveness Index, By Delivery Mode
• 6.2. Web-based*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Cloud-based
• 6.4. On-premise

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Health Management*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Home Health Management
• 7.4. Social and Behavioral Management
• 7.5. Financial Health Management

8. By Therapeutic Area

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
  • 8.1.2. Market Attractiveness Index, By Therapeutic Area
• 8.2. Hospitals & Clinics*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Fitness
• 8.4. Women's Health
• 8.5. Mental Health
• 8.6. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Providers*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Payers
• 9.4. Patients
• 9.5. Others

10. Competitive Landscape and Market Positioning

• 10.1. Competitive Overview and Key Market Players
• 10.2. Market Share Analysis and Positioning Matrix
• 10.3. Strategic Partnerships, Mergers & Acquisitions
• 10.4. Key Developments in Product Portfolios and Innovations
• 10.5. Company Benchmarking

11. Company Profiles

• 11.1. CureApp*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals, etc.
  • 11.1.5. SWOT Analysis
• 11.2. Oracle Corporation
• 11.3. NTT Data
• 11.4. Fujitsu Limited
• 11.5. M3

LIST NOT EXHAUSTIVE

12. Assumptions and Research Methodology

• 12.1. Data Collection Methods
• 12.2. Data Triangulation
• 12.3. Forecasting Techniques
• 12.4. Data Verification and Validation

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us